Catalyst Wire Dossier Catalyst Wire Dossier

ASC50

· Ascletis Pharma (China) Co., Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASC50, covering 2025-06-17 to 2025-06-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis [Phase 1]

See pricing